Introduction. Mutations in circulating nucleic acids are biomarkers for the early detection and management of hepatocellular carcinoma (HCC). While circulating tumor DNA (ctDNA) and microRNA have been

DataCite Commons2025-06-01 更新60

Single cell and plasma RNA sequencing

肝细胞癌液体活检

单细胞RNA测序

Single cell and plasma RNA sequencing for RNA liquid biopsy for hepatocellular carcinomaEGA study EGAS00001005194

NIAID Data Ecosystem50

Additional file 6 of Identification and monitoring of mutations in circulating cell-free tumor DNA in hepatocellular carcinoma treated with lenvatinib

肝细胞癌液体活检

靶向治疗突变监测

Additional file 6.

Figshare2021-06-26 更新30

Additional file 4 of Identification and monitoring of mutations in circulating cell-free tumor DNA in hepatocellular carcinoma treated with lenvatinib

资源简介：

Additional file 4 of Identification and monitoring of mutations in circulating cell-free tumor DNA in hepatocellular carcinoma treated with lenvatinib

资源简介：

相关数据集